Last reviewed · How we verify
Opioid-Based Anesthesia-Analgesia Strategy
At a glance
| Generic name | Opioid-Based Anesthesia-Analgesia Strategy |
|---|---|
| Also known as | Opioid-Based Anesthesia, OBA-A |
| Sponsor | University of Crete |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- ERAS (Enhanced Recovery After Surgery) and Multimodal Analgesia in Laparoscopic Cholecystectomy
- Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery (NA)
- Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes (NA)
- Effect of Patient Preference for Intraoperative Opioid Use on Early Postoperative Quality of Recovery (NA)
- Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
- Opioid-free Anesthesia Protocol for Neurosurgical Supratentorial Tumor Resection (NA)
- Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair (PHASE4)
- Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: